Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poolbeg Pharma announces expansion of POLB 001 into oncology

By: TheNewswire.com
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  238.47
-5.72 (-2.34%)
AAPL  292.54
+1.99 (0.68%)
AMD  454.37
-21.14 (-4.45%)
BAC  54.70
+0.28 (0.52%)
GOOG  354.60
-7.69 (-2.12%)
META  573.22
-11.37 (-1.94%)
MSFT  399.10
-4.31 (-1.07%)
NVDA  201.44
-6.75 (-3.24%)
ORCL  202.41
-3.40 (-1.65%)
TSLA  382.70
-13.98 (-3.52%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.